Gran Lab Ltd

Gran Lab Ltd

Gran Lab helps people suffering from skin diseases.

HQ location
Belfast, United Kingdom
Website
Launch date
Employees
Company register number
  • Edit
Notes (0)
More about Gran Lab Ltd
Made with AI
Edit

Gran Lab Ltd is a biotechnology company focused on dermatological care, operating from its laboratory in Belfast, Northern Ireland. The firm was incorporated on March 27, 2024, by Dr. Pragya Sharma. Dr. Sharma, a medical doctor and biochemist with a PhD from Queen's University Belfast, was inspired to start the company after her grandmother struggled with psoriasis and the adverse side effects of steroid-based treatments. This personal experience fueled the company's mission to develop effective, steroid-free solutions for chronic skin conditions.

The company develops 'cosmeceutical' treatments for psoriasis and eczema, aiming to provide relief without the harsh side effects associated with traditional steroid medications. Its formulations are distinguished by their use of naturally derived bioactives, vitamins, and minerals, combined with molecular science. The products are designed to be colour-inclusive, catering to a diverse global consumer base. A key feature of Gran Lab's formulation is the inclusion of bio-minerals and rare earth metals intended to enhance the anti-inflammatory and antioxidant properties of the core compounds. A proof-of-concept study showed promising results, with 60% of participants remaining symptom-free at a four-year follow-up.

Gran Lab operates in the biotechnology and skincare markets, specifically targeting individuals suffering from chronic inflammatory skin conditions like eczema and psoriasis. The business functions as a Queen's University Belfast spin-in and has established its laboratory in the Medical Biology Centre. Having secured over £800,000 in initial funding from investors including QUBIS, Innovate UK, and Techstart Ventures, the company is advancing its treatments through clinical trials. The business model is focused on commercializing its proprietary formulations, with a planned market entry in the UK and USA in 2026 after obtaining regulatory approvals.

Keywords: dermatological care, psoriasis treatment, eczema solution, steroid-free skincare, biotechnology, cosmeceutical, bioactives, molecular science, skin health, Queen's University Belfast spin-in, Pragya Sharma, chronic skin conditions, natural ingredients, clinical trials, MedTech, HealthTech, Life Sciences, colour-inclusive skincare, anti-inflammatory skincare, antioxidant skincare

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads